# EPTIFIBATIDE
> **ANDA204693** · Abbreviated New Drug Application (Generic) · Sponsor: SAGENT PHARMS INC · Approved 2018-03-07
## Drug
- **FDA Application Number:** ANDA204693
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** EPTIFIBATIDE
- **Generic name:** EPTIFIBATIDE
- **Active ingredients:** EPTIFIBATIDE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** SAGENT PHARMS INC
- **Manufacturer:** Sagent Pharmaceuticals
- **First approval:** 2018-03-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204693)
---
*AI Analytics · CC0 1.0*